microDimensions to host two compact digital pathology webinars on 11 October, 2016

microDimensions is hosting two compact digital pathology webinars back to back on Oct 11th. The first session on “3D Histology” will show how to reconstruct 3D volumes from serial histological sections (brightfield or fluorescence), how to view and analyze them and how to perform volume measurements e.g. of tumors. The second session on "Multiplex Analysis of Brightfield Images" will focus on the automated alignment of differently stained brightfield images and how the aligned images can be used to speed up and facilitate the following analysis. Both webinars will be presented by Andreas Keil (PhD), the VP of Business Development at microDimensions.

Andreas Keil

Dates:

• "3D Histology", Tuesday, 11 Oct. 2016, 8 am PDT / 11 pm EDT / 17:00 CEST
• "Multiplex Analysis of Brightfield Images", Tuesday, 11 Oct. 2016, 8:30 am PDT / 11:30 pm EDT / 17:30 CEST

The attendance is free of charge. Interested attendees can register for one or both sessions here: https://micro-dimensions.com/webinars

Meet us at these upcoming exhibitions:

• Pathology Visions, 23 - 25 October 2016, San Diego, U.S.A.
• Munich Biomarker Conference, 29 - 30 November, Munich, Germany
• Digital Pathology Congress Europe, 1-2 December 2016, London, UK

To schedule an appointment at one of these exhibitions, please send an email with your

preferred date and time to [email protected]

About microDimensions

microDimensions develops and distributes software for microscopic image processing and analysis. Their solutions and services can be tailored to individual requirements and seamlessly integrated into digital pathology workflows. microDimensions’ cutting-edge products Voloom^®, Slidematch™ and Zoom are the world’s fastest tools for convenient and accurate 3D histology reconstruction, whole slide image alignment, and digital pathology viewing. They enable pharmaceutical and biotech companies to accelerate early drug testing and allow research organizations to gain new insights into cancer, multiple sclerosis, chronic infections, and other diseases.